The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors (TKIs) in patients (pts) with Philadelphia chromosome–positive (Ph+) leukemia: Phase 1/2 study update.
 
Carlo Gambacorti-Passerini
Honoraria - Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Pfizer (Inst)
 
Jeffrey Howard Lipton
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Andreas Hochhaus
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst)
 
Vamsi K. Kota
Consulting or Advisory Role - Incyte; Novartis; Pfizer; Takeda; Xcenda
Research Funding - Leukemia and Lymphoma Society (Inst)
 
Michele Baccarani
Honoraria - Incyte; Novartis
Consulting or Advisory Role - Incyte; Novartis
 
Simon Durrant
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Sarit E. Assouline
Consulting or Advisory Role - Lundbeck; Roche Canada
Speakers' Bureau - Bristol-Myers Squibb; Paladin; Pfizer
 
Dong-Wook Kim
Honoraria - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; IL-Yang Pharm; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); IL-Yang Pharm (Inst); Novartis (Inst); Pfizer (Inst)
 
Tim H. Brümmendorf
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fiona An
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jean Aguiar
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Novartis; Pfizer; Takeda
Research Funding - Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst)